Monaco Hickey was engaged to deliver a stand-alone PC3 AQUS certified vaccine facility for the manufacture of Q Fever Vaccine. The project included a design review with CSL, GMP Detailing, and constructability reviews with a range of consultants and CSL.
The Monaco Hickey team employed stringent containment techniques, along with careful detailing and construction methods to ensure the facility complied with OGTR and AQUS requirements.
Monaco Hickey achieved successful decay testing of the facility, establishing operational duct pressure and leakage rates to ensure the vaccines could be contained within the fabric of the production rooms and to enable certification from relevant regulatory authorities.
Monaco Hickey also assisted CSL with consultancy management, and delivered the project on time and within budget.
Stringent containment and construction techniques were employed to deliver a world leading vaccine facility.